Edition:
United Kingdom

MEDNAX Inc (MD.N)

MD.N on New York Stock Exchange

43.18USD
19 Oct 2018
Change (% chg)

$-2.12 (-4.68%)
Prev Close
$45.30
Open
$45.18
Day's High
$45.18
Day's Low
$43.02
Volume
279,051
Avg. Vol
236,962
52-wk High
$62.75
52-wk Low
$40.56

Latest Key Developments (Source: Significant Developments)

Mednax Appoints Stephen Farber As Executive Vice President, To Succeed CFO
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - MEDNAX Inc ::MEDNAX APPOINTS STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, TO SUCCEED CHIEF FINANCIAL OFFICER.MEDNAX INC - APPOINTMENT OF STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, EFFECTIVE AUGUST 27, 2018.MEDNAX INC - FARBER WILL ASSUME ADDITIONAL ROLE OF CHIEF FINANCIAL OFFICER IN NOVEMBER 2018.MEDNAX INC - FARBER TO SUCCEED VIVIAN LOPEZ-BLANCO, WHO RECENTLY ANNOUNCED HER PLANNED RETIREMENT FROM COMPANY.  Full Article

Mednax Reports Second Quarter GAAP EPS Of $0.85 Adjusted EPS Of $1.07
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS SECOND QUARTER GAAP EPS OF $0.85; ADJUSTED EPS OF $1.07.SEES Q3 2018 ADJUSTED EARNINGS PER SHARE $0.94 TO $0.99.SEES Q3 2018 EARNINGS PER SHARE $0.72 TO $0.77.Q2 ADJUSTED EARNINGS PER SHARE $1.07.Q2 EARNINGS PER SHARE $0.85.Q2 REVENUE $916 MILLION VERSUS I/B/E/S VIEW $912.4 MILLION.Q2 SAME STORE SALES ROSE 3.2 PERCENT.BOARD AUTHORIZES SHARE REPURCHASE OF UP TO $500 MILLION.Q2 EARNINGS PER SHARE VIEW $1.06 -- THOMSON REUTERS I/B/E/S.VIVIAN LOPEZ-BLANCO HAS INFORMED MEDNAX OF HER INTENT TO RETIRE AS CHIEF FINANCIAL OFFICER OF THE COMPANY.MEDNAX - TO CONDUCT A FORMAL SEARCH FOR A SUCCESSOR, LOPEZ-BLANCO WILL REMAIN THROUGHOUT THE SEARCH PROCESS AND FOR A TRANSITIONAL PERIOD THEREAFTER.FOR Q3 2018, EXPECTS EBITDA GROWTH BETWEEN THREE PERCENT AND EIGHT PERCENT LOWER, COMPARED TO THE PRIOR-YEAR PERIOD EBITDA OF $151.5 MILLION.  Full Article

Court Rejects Mednax's Request To Stop Atrium Health's Transition To Scope Anesthesia
Monday, 25 Jun 2018 

June 25 (Reuters) - Atrium Health::ATRIUM HEALTH - COURT REJECTED MEDNAX'S REQUEST FOR PRELIMINARY INJUNCTION STOPPING CO'S TRANSITION TO SCOPE ANESTHESIA, ON JULY 1.  Full Article

Mednax Inc Reports Adjusted EPS Of $0.89
Monday, 30 Apr 2018 

May 1 (Reuters) - MEDNAX Inc ::REPORTS ADJUSTED EPS OF $0.89.QTRLY EARNINGS PER SHARE $0.68.MEDNAX'S NET REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 INCREASED BY 7.9 PERCENT, TO $901.9 MILLION.SAME-UNIT REVENUE FROM NET REIMBURSEMENT-RELATED FACTORS INCREASED BY 2.1 PERCENT FOR 2018 Q1.FOR 2018 Q2, EXPECTS EARNINGS PER SHARE WILL BE IN A RANGE OF $0.81 TO $0.86 PER DILUTED SHARE.FOR 2018 Q2 EXPECTS ADJUSTED EPS WILL BE IN A RANGE OF $1.04 TO $1.09.FOR 2018 Q2, MEDNAX EXPECTS THAT EBITDA GROWTH WILL BE BETWEEN ONE PERCENT AND SIX PERCENT.OUTLOOK ASSUMES TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED JUNE 30, 2018 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.Q1 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $903.6 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S.  Full Article

Mednax Reports Q1 EPS Of $0.68
Monday, 30 Apr 2018 

April 30 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS FIRST QUARTER GAAP EPS OF $0.68.SEES Q2 2018 ADJUSTED EARNINGS PER SHARE $1.04 TO $1.09.SEES Q2 2018 EARNINGS PER SHARE $0.81 TO $0.86.Q1 ADJUSTED EARNINGS PER SHARE $0.89.Q1 EARNINGS PER SHARE $0.68.Q1 REVENUE $902 MILLION VERSUS I/B/E/S VIEW $903.6 MILLION.Q1 SAME STORE SALES ROSE 3.5 PERCENT.Q1 EARNINGS PER SHARE VIEW $0.86 -- THOMSON REUTERS I/B/E/S.  Full Article

Mednax Inc Reports Qtrly EPS Of $0.68
Monday, 30 Apr 2018 

April 30 (Reuters) - MEDNAX Inc ::QTRLY EARNINGS PER SHARE $0.68.MEDNAX'S NET REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 INCREASED BY 7.9 PERCENT, TO $901.9 MILLION.SAME-UNIT REVENUE FROM NET REIMBURSEMENT-RELATED FACTORS INCREASED BY 2.1 PERCENT FOR 2018 Q1.SEES ADJUSTED EPS OF $0.89.FOR 2018 Q2, EXPECTS EARNINGS PER SHARE WILL BE IN A RANGE OF $0.81 TO $0.86 PER DILUTED SHARE.FOR 2018 Q2 EXPECTS ADJUSTED EPS WILL BE IN A RANGE OF $1.04 TO $1.09.FOR 2018 Q2, MEDNAX EXPECTS THAT EBITDA GROWTH WILL BE BETWEEN ONE PERCENT AND SIX PERCENT.OUTLOOK ASSUMES TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED JUNE 30, 2018 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.Q1 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $903.6 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S.  Full Article

MEDNAX Reports Acquisition Of Leading Texas Radiology Practice
Tuesday, 24 Apr 2018 

April 24 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF LEADING TEXAS RADIOLOGY PRACTICE.MEDNAX INC - NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.MEDNAX INC - DEAL WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.  Full Article

Mednax Inc Announces Expansion Of Radiology Practices
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Mednax Inc ::MEDNAX ANNOUNCES EXPANSION OF RADIOLOGY PRACTICES.MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED.​.MEDNAX INC - ACQUIRES COOL SPRINGS INTERVENTIONAL, LLC BASED IN FRANKLIN, TENN.MEDNAX INC - ‍COOL SPRINGS INTERVENTIONAL WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS​.  Full Article

Mednax Announces Acquisition Of Neonatology Practice In California
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Mednax Inc ::MEDNAX INC - ‍NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED​.MEDNAX - DEAL WAS CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.MEDNAX ANNOUNCES ACQUISITION OF NEONATOLOGY PRACTICE IN CALIFORNIA.  Full Article

Elliott, Elliott International & EICA collectively combines economic exposure in MEDNAX
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDNAX Inc :Elliott says Elliott, Elliott International & EICA collectively have combined economic exposure in MEDNAX of about 7.0% of stock as of Nov 6.‍Elliott​ Managemenet- believe MEDNAX Securities undervalued; seek to engage with MEDNAX management,board on strategic options,operational opportunities.‍Elliott​ Managemenet- may propose potential changes in operations, management, board, potential strategic transactions involving mednax, some assets, among others.Elliott​ Management says intends to talk with MEDNAX's management about operational matters, including sale of MEDNAX or some of its businesses.  Full Article

Chanos shorts Envision, says KKR may get cold feet on deal

NEW YORK Hedge fund manager Jim Chanos says he is betting that the stocks of physican practice management companies Mednax and Envision Healthcare will fall and said that private equity group KKR might get cold feet on a planned deal for Envision.